Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 12/2011

01-12-2011 | Clinical Research

Gastric By-pass with Fixed 230-cm-Long Common Limb and Variable Alimentary and Biliopancreatic Limbs in Morbid Obesity

Authors: José Hernández-Martínez, Miguel Ángel Calvo-Ros

Published in: Obesity Surgery | Issue 12/2011

Login to get access

Abstract

Background

Morbid obesity is a disease of increasing prevalence. Diet and exercise are not effective for excess weight loss (EWL) in most patients; therefore, different bariatric surgery procedures based in restriction or malabsorption, or a combination of both, i.e., the Roux-en-Y gastric by-pass (RYGBP) hybrid operation, have been established. Here, we report the outcome of a modified RYGBP operation in 565 obese patients.

Methods

Our modified RYGBP operation consisted of a pouch smaller than 25 cc, a fixed common limb of 230 cm, and the rest of the small bowel redistributed among the alimentary channel (60%) and the biliopancreatic channel (40%).

Results

A large variation in the whole length of small bowel was observed (380–820 cm). EWL was gradually increasing from month 1 after surgery (20.1%) to month 12 (70.1%); this value was maintained in the 2–8-year follow-up period. No differences in fecal protein and carbohydrate loss, before and after surgery, were seen; in contrast, three- to tenfold-higher lipid loss was produced after surgery. Long-term complications were scarce (28 patients with chronic anemia, 3 patients with flatulence, and 8 patients with mild diarrhea).

Conclusions

Gastric pouch smaller than 25 cc and measurement of the entire small bowel length during RYGBP surgery, leaving a 230-cm length of common limb and redistributing the remaining 60% in the alimentary channel and 40% in the biliopancreatic channel produced sustained EWL with few secondary nutrient deficits along an 8-year follow-up period.
Literature
1.
Calle EE, Thun MJ, Petrelli JM, et al. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med. 1999;341:1097–105.PubMedCrossRef
2.
WHO, Obesity: preventing and managing the global epidemic, in Report on a World Health Organization Consultation on Obesity 1998: Geneva.
3.
Deitel M, Shikora SA. The development of the surgical treatment of morbid obesity. J Am Coll Nutr. 2002;21:365–71.PubMed
4.
Mason EE, Ito C. Gastric bypass in obesity. Surg Clin North Am. 1967;47:1345–51.PubMed
5.
Pories WJ, Swanson MS, MacDonald KG, et al. Who would have thought it? An operation proves to be the most effective therapy for adult-onset diabetes mellitus. Ann Surg. 1995;222:339–50. discussion 350–2.PubMedCrossRef
6.
Fobi MA. Vertical banded gastroplasty vs gastric bypass: 10 years follow-up. Obes Surg. 1993;3:161–4.PubMedCrossRef
7.
Jones Jr KB. Experience with the Roux-en-Y gastric bypass, and commentary on current trends. Obes Surg. 2000;10:183–5.PubMedCrossRef
8.
MacLean LD, Rhode BM, Nohr CW. Late outcome of isolated gastric bypass. Ann Surg. 2000;231:524–8.PubMedCrossRef
9.
Sugerman HJ, Kellum JM, DeMaria EJ. Conversion of proximal to distal gastric bypass for failed gastric bypass for superobesity. J Gastrointest Surg. 1997;1:517–24. discussion 524–6.PubMedCrossRef
10.
Fobi MA, Lee H, Igwe Jr D, et al. Revision of failed gastric bypass to distal Roux-en-Y gastric bypass: a review of 65 cases. Obes Surg. 2001;11:190–5.PubMedCrossRef
11.
Brolin RE, Kenler HA, Gorman JH, et al. Long-limb gastric bypass in the superobese. A prospective randomizeed study. Ann Surg. 1992;215:387–95.PubMedCrossRef
12.
13.
Choban PS, Flancbaum L. The effect of Roux limb lengths on outcome after Roux-en-Y gastric bypass: a prospective, randomized clinical trial. Obes Surg. 2002;12:540–5.PubMedCrossRef
14.
Scopinaro N, Gianetta E, Adami GF, et al. Biliopancreatic diversion for obesity at eighteen years. Surgery. 1996;119:261–8.PubMedCrossRef
15.
Kim JJ, Tarnoff ME, Shikora SA. Surgical treatment for extreme obesity: evolution of a rapidly growing field. Nutr Clin Pract. 2003;18:109–23.PubMedCrossRef
16.
Biron S, Hould FS, Lebel S, et al. Twenty years of biliopancreatic diversion: what is the goal of the surgery? Obes Surg. 2004;14:160–4.PubMedCrossRef
17.
Rabkin RA, Rabkin JM, Metcalf B, et al. Nutritional markers following duodenal switch for morbid obesity. Obes Surg. 2004;14:84–90.PubMedCrossRef
18.
Sugerman HJ, Londrey GL, Kellum JM, et al. Weight loss with vertical banded gastroplasty and Roux-Y gastric bypass for morbid obesity with selective versus random assignment. Am J Surg. 1989;157:93–102.PubMedCrossRef
19.
Leifsson BG, Gislason HG. Laparoscopic Roux-en-Y gastric bypass with 2-metre long biliopancreatic limb for morbid obesity: technique and experience with the first 150 patients. Obes Surg. 2005;15:35–42.PubMedCrossRef
20.
Freeman JB, Kotlarewsky M, Phoenix C. Weight loss after extended gastric bypass. Obes Surg. 1997;7:337–44.PubMedCrossRef
21.
MacLean LD, Rhode BM, Nohr CW. Long- or short-limb gastric bypass? J Gastrointest Surg. 2001;5:525–30.PubMedCrossRef
22.
Feng JJ, Gagner M, Pomp A, et al. Effect of standard vs extended Roux limb length on weight loss outcomes after laparoscopic Roux-en-Y gastric bypass. Surg Endosc. 2003;17:1055–60.PubMedCrossRef
23.
Inabnet WB, Quinn T, Gagner M, et al. Laparoscopic Roux-en-Y gastric bypass in patients with BMI <50: a prospective randomized trial comparing short and long limb lengths. Obes Surg. 2005;15:51–7.PubMedCrossRef
24.
25.
Ahrens Jr EH, Blankenhorn DH, Hirsch J. Measurement of the human intestinal length in vivo and some causes of variation. Gastroenterology. 1956;31:274–84.PubMed
26.
Fanucci A, Cerro P, Fraracci L, et al. Small bowel length measured by radiography. Gastrointest Radiol. 1984;9:349–51.PubMedCrossRef
27.
Kjeldahl JA. A new method for the determination of nitrogen in organic matter. Zeitschreft fur Analytische Chemie. 1883;22:366–82.CrossRef
28.
Van der Kamer JH, Ten Bokkel HH, Weyers H. Rapid method for the determination of fat in feces. J Biol Chem. 1949;177:347–55.
29.
Clegg KM. The application of the anthrone reagent to the estimation of starch in cereals. J Sci Food Agric. 1956;7:40.CrossRef
30.
Brolin RE, Kenler HA, Gorman RC, et al. The dilemma of outcome assessment after operations for morbid obesity. Surgery. 1989;105:337–46.PubMed
31.
Flancbaum L. Mechanisms of weight loss after surgery for clinically severe obesity. Obes Surg. 1999;9:516–23.PubMedCrossRef
32.
Fobi MA, Lee H, Holness R, et al. Gastric bypass operation for obesity. World J Surg. 1998;22:925–35.PubMedCrossRef
33.
Murr MM, Balsiger BM, Kennedy FP, et al. Malabsorptive procedures for severe obesity: comparison of pancreaticobiliary bypass and very very long limb Roux-en-Y gastric bypass. J Gastrointest Surg. 1999;3:607–12.PubMedCrossRef
34.
Sarr MG. Motility and absorption in the transplanted gut. Transplant Proc. 1996;28:2535–8.PubMed
35.
Wittgrove AC, Clark GW. Laparoscopic gastric bypass, Roux-en-Y- 500 patients: technique and results, with 3–60 month follow-up. Obes Surg. 2000;10:233–9.PubMedCrossRef
36.
Date Y, Kojima M, Hosoda H, et al. Ghrelin, a novel growth hormone-releasing acylated peptide, is synthesized in a distinct endocrine cell type in the gastrointestinal tracts of rats and humans. Endocrinology. 2000;141:4255–61.PubMedCrossRef
37.
Fruhbeck G, Diez-Caballero A, Gil MJ, et al. The decrease in plasma ghrelin concentrations following bariatric surgery depends on the functional integrity of the fundus. Obes Surg. 2004;14:606–12.PubMedCrossRef
38.
Cummings DE, Weigle DS, Frayo RS, et al. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med. 2002;346:1623–30.PubMedCrossRef
39.
Schauer PR, Ikramuddin S, Gourash W, et al. Outcomes after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Ann Surg. 2000;232:515–29.PubMedCrossRef
40.
Higa KD, Ho T, Boone KB. Laparoscopic Roux-en-Y gastric bypass: technique and 3-year follow-up. J Laparoendosc Adv Surg Tech A. 2001;11:377–82.PubMedCrossRef
41.
Nguyen NT, Rivers R, Wolfe BM. Factors associated with operative outcomes in laparoscopic gastric bypass. J Am Coll Surg. 2003;197:548–55. discussion 555–7.PubMedCrossRef
42.
Gould JC, Needleman BJ, Ellison EC, et al. Evolution of minimally invasive bariatric surgery. Surgery. 2002;132:565–71. discussion 571–2.PubMedCrossRef
43.
DeMaria EJ, Sugerman HJ, Kellum JM, et al. Results of 281 consecutive total laparoscopic Roux-en-Y gastric bypasses to treat morbid obesity. Ann Surg. 2002;235:640–5. discussion 645–7.PubMedCrossRef
44.
del Val Díez, Martínez-Blázquez IC, Valencia-Cortejoso J, et al. Bypass gástrico. Cir Esp. 2004;75:244–50.
45.
Biertho L, Steffen R, Ricklin T, et al. Laparoscopic gastric bypass versus laparoscopic adjustable gastric banding: a comparative study of 1,200 cases. J Am Coll Surg. 2003;197:536–44. discussion 544–5.PubMedCrossRef
46.
Olbers T, Lonroth H, Fagevik-Olsen M, et al. Laparoscopic gastric bypass: development of technique, respiratory function, and long-term outcome. Obes Surg. 2003;13:364–70.PubMedCrossRef
Metadata
Title
Gastric By-pass with Fixed 230-cm-Long Common Limb and Variable Alimentary and Biliopancreatic Limbs in Morbid Obesity
Authors
José Hernández-Martínez
Miguel Ángel Calvo-Ros
Publication date
01-12-2011
Publisher
Springer-Verlag
Published in
Obesity Surgery / Issue 12/2011
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-011-0432-z

Other articles of this Issue 12/2011

Obesity Surgery 12/2011 Go to the issue

Clinical Research

Getting the Most from the Sleeve: The Importance of Post-Operative Follow-up

Case Report

The Importance of Methylmalonic Acid Dosage on the Assessment of Patients with Neurological Manifestations Following Bariatric Surgery

Current Status

An Assessment of Patient Behavioral Requirements Pre- and Post-Surgery at Accredited Weight Loss Surgical Centers

Clinical Research

Physical Activity After Surgery for Severe Obesity: The Role of Exercise Cognitions

Physiology Research

Pancreatic Polypeptide Meal Response May Predict Gastric Band-Induced Weight Loss

Editorial

With Thanks and Gratitude